Beta-Blocker Therapy in Severe Traumatic Brain Injury: A Prospective Randomized Controlled Trial

ConclusionPropranolol decreases in-hospital mortality and improves long-term functional outcome in isolated severe TBI. This randomized trial speaks in favor of routine administration of beta-blocker therapy as part of a standardized neurointensive care protocol.Level of evidenceLevel II; therapeutic.Study typeTherapeutic study.

http://link.springer.com/10.1007/s00268-020-05391-8

Source: World Journal of Surgery - April 28, 2020 Category: Surgery Source Type: research